02696.HK
Shanghai Henlius Biotech, Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 59.70
+2.23%Forward multiples
Based on analyst estimates
- P/E forward
- 21.89x
- P/E 2026E
- 24.94x
- P/E 2027E
- 27.92x
- P/E 2028E
- 20.96x
- P/S forward
- 2.27x
Trailing multiples
Trailing twelve months
- P/E TTM
- 32.11x
- PEG TTM
- 0.69x
- Price / book
- 6.11x
- Price / sales
- 3.73x
- Price / cash flow
- 51.89x
Enterprise value
- Enterprise value
- HKD 35.9B
- EV / sales
- 4.13x
- EV / EBITDA
- 25.11x
- EV / EBIT
- 34.29x
- Market cap
- HKD 32.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026